Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinbei oral liquid for pneumoconiosis
ChiCTR2500104380Phase 4Completed
- Sponsor
- Shandong First Medical University Affiliated Occupational Disease Hospital
- Start
- Jun 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Jinbei oral liquid in pneumoconiosis (2 arms), sponsored by Shandong First Medical University Affiliated Occupational Disease Hospital. Primary endpoints: Change in FEV1, FVC, and TLC from baseline and between-group differences, Changes in TCM syndrome score and efficacy evaluations and 6 more. Started Jun 2025; status: completed.
02
Drugs
Jinbei oral liquid
03
Conditions
pneumoconiosis
Beyond the preview
Go deeper on ChiCTR2500104380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104380.